Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Picornaviridae Infections | 8 | 2016 | 55 | 1.660 |
Why?
|
| Rhinovirus | 6 | 2016 | 67 | 1.270 |
Why?
|
| Common Cold | 5 | 2016 | 35 | 1.260 |
Why?
|
| Respiratory Tract Infections | 6 | 2016 | 408 | 0.990 |
Why?
|
| Coronavirus | 3 | 2016 | 37 | 0.910 |
Why?
|
| Coronavirus Infections | 3 | 2016 | 632 | 0.700 |
Why?
|
| Virus Diseases | 3 | 2005 | 392 | 0.390 |
Why?
|
| National Library of Medicine (U.S.) | 1 | 2008 | 10 | 0.310 |
Why?
|
| Internet | 2 | 2008 | 702 | 0.260 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2010 | 1062 | 0.250 |
Why?
|
| Education, Medical | 1 | 2008 | 344 | 0.220 |
Why?
|
| Respiratory Tract Diseases | 1 | 2003 | 111 | 0.200 |
Why?
|
| Influenza, Human | 3 | 2006 | 763 | 0.170 |
Why?
|
| Immunocompromised Host | 3 | 2011 | 721 | 0.160 |
Why?
|
| Bacteremia | 1 | 2005 | 722 | 0.160 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2005 | 434 | 0.160 |
Why?
|
| Cytomegalovirus Infections | 1 | 2002 | 487 | 0.150 |
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 1 | 2016 | 25 | 0.140 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2016 | 84 | 0.130 |
Why?
|
| Acute Disease | 3 | 2007 | 2509 | 0.130 |
Why?
|
| Otitis Media | 2 | 2007 | 81 | 0.120 |
Why?
|
| Sinusitis | 2 | 2007 | 148 | 0.110 |
Why?
|
| Antiviral Agents | 3 | 2007 | 1255 | 0.110 |
Why?
|
| Cystic Fibrosis | 2 | 2007 | 294 | 0.100 |
Why?
|
| Picornaviridae | 1 | 2011 | 21 | 0.100 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2005 | 309 | 0.100 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2005 | 370 | 0.090 |
Why?
|
| Hospitalization | 2 | 2011 | 2181 | 0.080 |
Why?
|
| Cysteine Endopeptidases | 1 | 2010 | 265 | 0.080 |
Why?
|
| Libraries, Medical | 1 | 2008 | 7 | 0.080 |
Why?
|
| PubMed | 1 | 2008 | 33 | 0.080 |
Why?
|
| History, 19th Century | 1 | 2008 | 145 | 0.070 |
Why?
|
| Viral Proteins | 1 | 2010 | 493 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 3649 | 0.070 |
Why?
|
| Asthma | 2 | 2007 | 894 | 0.070 |
Why?
|
| Viridans Streptococci | 1 | 2006 | 17 | 0.070 |
Why?
|
| Penicillin Resistance | 1 | 2006 | 85 | 0.070 |
Why?
|
| Ceftriaxone | 1 | 2006 | 77 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2008 | 422 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2008 | 550 | 0.060 |
Why?
|
| Humans | 17 | 2016 | 271887 | 0.060 |
Why?
|
| Medical Informatics | 1 | 2008 | 195 | 0.060 |
Why?
|
| Influenza A virus | 1 | 2006 | 166 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 1054 | 0.060 |
Why?
|
| Endocarditis, Bacterial | 1 | 2006 | 152 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 3512 | 0.060 |
Why?
|
| Hospitals, Teaching | 1 | 2005 | 128 | 0.060 |
Why?
|
| Cryptococcosis | 1 | 2005 | 70 | 0.060 |
Why?
|
| Patient-Centered Care | 1 | 2008 | 321 | 0.060 |
Why?
|
| Teaching | 1 | 2005 | 252 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2005 | 234 | 0.060 |
Why?
|
| Rhinitis | 1 | 2003 | 40 | 0.050 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2002 | 173 | 0.050 |
Why?
|
| Influenza Vaccines | 1 | 2006 | 492 | 0.050 |
Why?
|
| Seasons | 1 | 2002 | 337 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2006 | 1297 | 0.040 |
Why?
|
| Viral Vaccines | 1 | 2002 | 358 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2002 | 493 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2002 | 438 | 0.040 |
Why?
|
| Recurrence | 2 | 2005 | 4887 | 0.040 |
Why?
|
| United States | 2 | 2008 | 16016 | 0.040 |
Why?
|
| Aged | 6 | 2011 | 73478 | 0.030 |
Why?
|
| Inflammation | 1 | 2005 | 2533 | 0.030 |
Why?
|
| Risk Factors | 2 | 2002 | 18019 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 3177 | 0.030 |
Why?
|
| Age Factors | 1 | 2002 | 5515 | 0.030 |
Why?
|
| Virus Cultivation | 1 | 2011 | 80 | 0.020 |
Why?
|
| Serologic Tests | 1 | 2011 | 150 | 0.020 |
Why?
|
| Viruses | 1 | 2011 | 156 | 0.020 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2010 | 49 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2010 | 291 | 0.020 |
Why?
|
| Male | 7 | 2011 | 128993 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2010 | 269 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2010 | 253 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2010 | 260 | 0.020 |
Why?
|
| Prognosis | 1 | 2005 | 22538 | 0.020 |
Why?
|
| Adult | 4 | 2011 | 81935 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2010 | 1180 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2006 | 249 | 0.020 |
Why?
|
| Female | 5 | 2011 | 149201 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 1728 | 0.020 |
Why?
|
| Family Practice | 1 | 2005 | 132 | 0.020 |
Why?
|
| Metapneumovirus | 1 | 2005 | 57 | 0.020 |
Why?
|
| Paramyxoviridae Infections | 1 | 2005 | 72 | 0.020 |
Why?
|
| Pneumonia | 1 | 2010 | 798 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2010 | 1113 | 0.010 |
Why?
|
| Hypolipidemic Agents | 1 | 2005 | 190 | 0.010 |
Why?
|
| Prevalence | 1 | 2011 | 3415 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 2005 | 234 | 0.010 |
Why?
|
| Middle Aged | 5 | 2011 | 90414 | 0.010 |
Why?
|
| Streptococcal Infections | 1 | 2006 | 318 | 0.010 |
Why?
|
| Outpatients | 1 | 2006 | 467 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2005 | 39812 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 2005 | 353 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 5783 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2005 | 629 | 0.010 |
Why?
|
| Opportunistic Infections | 1 | 2002 | 237 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 31061 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 7234 | 0.010 |
Why?
|
| Syndrome | 1 | 2002 | 1407 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 8629 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 5103 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2005 | 1233 | 0.010 |
Why?
|
| Mass Screening | 1 | 2005 | 1547 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 13987 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 15264 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 17062 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2006 | 33905 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 22159 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 32738 | 0.010 |
Why?
|
| Child | 1 | 2011 | 30564 | 0.010 |
Why?
|
| Mice | 1 | 2010 | 36017 | 0.010 |
Why?
|
| Animals | 1 | 2010 | 62766 | 0.000 |
Why?
|